https://www.globenewswire.com/news-release/2018/02/05/1332835/0/en/Sorrento-s-and-Yuhan-s-Joint-Venture-ImmuneOncia-receives-Approval-to-begin-clinical-trial-of-Anti-PD-L1-Monoclonal-Antibody-in-South-Korea.html